Goldman Sachs’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-323,663
| Closed | -$9.77M | – | 4767 |
|
|
2016
Q2 | $9.77M | Buy |
323,663
+245,481
| +314% | +$7.41M | ﹤0.01% | 1778 |
|
|
2016
Q1 | $862K | Buy |
+78,182
| New | +$862K | ﹤0.01% | 2938 |
|
|
2015
Q4 | – | Sell |
-34,795
| Closed | -$58K | – | 4754 |
|
|
2015
Q3 | $58K | Buy |
+34,795
| New | +$58K | ﹤0.01% | 4315 |
|
|
2015
Q2 | – | Sell |
-11,550
| Closed | -$29K | – | 4845 |
|
|
2015
Q1 | $29K | Buy |
+11,550
| New | +$29K | ﹤0.01% | 4376 |
|